PULM
Pulmatrix, Inc.
-0.01 (-0.71%)1.39USD8.4K成交股數5.1M市值–本益比(近四季)2.6股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | 53K-99% | 3K-100% | 366K-80% | 1.6M+4% | 5.9M | 1.8M | 1.8M | 1.5M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 2K | 3K | 8K | 14K | 19K | 6K | 814K | 2.8M | 3.5M | 4.0M | 4.2M | 3.9M |
| 銷售管理費用 | 1.0M | 1.3M | 858K | 1.5M | 1.8M | 1.9M | 2.2M | 2.0M | 1.6M | 1.7M | 1.7M | 2.2M |
| 營業利益 | −1.0M-43% | −1.3M-34% | −866K-67% | −1.5M-74% | −1.8M-347% | −2.0M-50% | −2.7M-33% | −5.9M+29% | 747K | −3.9M | −4.0M | −4.6M |
| 營業利益率 | – | – | – | – | -3,484.9% | -65,066.7% | -726.0% | -380.2% | 12.7% | -224.7% | -216.4% | -305.9% |
| 稅後淨利 | −1.0M-43% | −1.2M-41% | −877K-66% | −1.5M-73% | −1.8M-319% | −2.0M-47% | −2.6M-32% | −5.8M+31% | 825K | −3.8M | −3.8M | −4.4M |
| 淨利率 | – | – | – | – | -3,411.3% | -66,200.0% | -706.8% | -374.4% | 14.0% | -215.3% | -206.9% | -296.7% |
| 稀釋 EPS | -0.29-42% | -0.32-42% | -0.24-66% | -0.42-74% | -0.50-317% | -0.55-47% | -0.71-32% | -1.59+30% | 0.23 | -1.03 | -1.04 | -1.22 |
| 稀釋股數 | 3.7M | 3.7M | 3.7M | 3.7M | 3.7M | 3.7M | 3.7M | 3.7M | 3.7M | 3.7M | 3.7M | 3.7M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 2.2M | 3.3M | 4.8M | 5.8M | 7.7M | 9.5M | 10.8M | 12.4M | 16.3M | 21.3M | 25.8M | 30.8M |
| 應收帳款 | – | – | – | – | 16K | – | 23K | 635K | 570K | 841K | 418K | 740K |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 3.2M | 4.5M | 5.0M | 6.2M | 8.1M | 9.9M | 11.5M | 15.8M | 30.4M | 36.8M | 31.4M | 36.1M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 689K | 905K | 249K | 548K | 904K | 996K | 590K | 2.5M | 11.4M | 16.9M | 7.9M | 9.0M |
| 股東權益 | 2.6M | 3.6M | 4.7M | 5.6M | 7.1M | 8.9M | 10.9M | 13.3M | 19.0M | 19.9M | 23.4M | 27.0M |
| 負債比 | 21.2% | 20.1% | 5.0% | 8.9% | 11.2% | 10.0% | 5.1% | 15.7% | 37.4% | 45.9% | 25.3% | 25.1% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −1.1M | – | – | −1.8M-33% | – | – | – | −2.7M | – | – | −4.9M |
| 資本支出 | – | – | – | – | – | – | – | – | 154K | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | −2.9M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | 59K | – | – | 32K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | -48.8% | – | – | – |
營收拆解 2020 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2020 年度 · 1.6M
| Toxicology Study Costs | 1.6M | 100.0% | – |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −5.2M | –% | -1.41 | – |
| FY2024 | 7.8M | +7.0% | −9.6M | -122.5% | -2.62 | −11.1M |
| FY2023 | 7.3M | +20.2% | −14.1M | -193.5% | -3.87 | −16.7M |
| FY2022 | 6.1M | +17.5% | −18.8M | -310.3% | -5.46 | −19.4M |
| FY2021 | 5.2M | -59.1% | −20.2M | -390.2% | -8.63 | −19.9M |
| FY2020 | 12.6M | +59.7% | −19.3M | -152.8% | -13.43 | −12.8M |
| FY2019 | 7.9M | +5069.9% | −20.6M | -260.4% | -1.23 | 3.2M |
| FY2018 | 153K | – | −20.6M | -13,439.9% | -4.98 | −16.8M |